SCHEMBL9693393

SCHEMBL9693393

CCOP(=O)(OCC)C1C(=O)NC(=O)N1CC(C)C

nearest known ligand 0.33

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 1/20 0.33
GAA P10253 1/20 0.33
ADRA2A P08913 1/20 0.31
NISCH Q9Y2I1 1/20 0.31
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9693632 0.84 GAA (0.36) GAAADRA2ANISCHMEN1KMT2A
SCHEMBL9693373 0.81 ADRA2A (0.35) GAAADRA2ANISCHMEN1KMT2A
SCHEMBL9163076 0.79 GAA (0.38) GAAADRA2ANISCHMEN1KMT2A
SCHEMBL9693427 0.78 GAA (0.35) GAAADRA2ANISCH
SCHEMBL4370549 0.76 ADRA2A (0.37) GAAADRA2ANISCHMEN1KMT2A
SCHEMBL9597453 0.75 CYP3A4 (0.36) GAA
SCHEMBL1363366 0.70 PIK3CD (0.41) PIK3CD
SCHEMBL7044026 0.68 PIK3CD (0.42) PIK3CD
SCHEMBL1362959 0.64 PIK3CD (0.39) PIK3CDMEN1KMT2A
SCHEMBL10657841 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0252503-B1 AMINOIMIDAZOQUINOLINE DERIVATIVES Bristol-Myers Squibb Company (US) 1992-11-19 EP disclosed
EP-0252503-A1 Aminoimidazoquinoline derivatives Bristol-Myers Squibb Company (US) 1988-01-13 EP disclosed
US-4701459-A 7-amino-1,3-dihydro-2H-imidazo[4,5-b]quinolin 2-ones and method for inhibiting phosphodiesterase and blood platelet aggregation BRISTOL-MYERS COMPANY (US) 1987-10-20 US disclosed
US-4668686-A 1,3-DIHYDRO-2H-IMIDAZO/4,5-B/QUINOLINE-2-ONES BRISTOL-MYERS COMPANY (US) 1987-05-26 US disclosed